Molecular Basis of CLC Antiporter Inhibition by Fluoride.


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
22 04 2020
Historique:
pubmed: 3 4 2020
medline: 16 4 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

CLC channels and transporters conduct or transport various kinds of anions, with the exception of fluoride, which acts as an effective inhibitor. Here, we performed sub-nanosecond DFT-based QM/MM simulations of the

Identifiants

pubmed: 32233472
doi: 10.1021/jacs.9b13588
doi:

Substances chimiques

Antiporters 0
Chlorides 0
Fluorides Q80VPU408O

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

7254-7258

Auteurs

Maria Gabriella Chiariello (MG)

Institute for Advanced Simulation (IAS-5) and Institute of Neuroscience and Medicine (INM-9), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
JARA-HPC, Forschungszentrum Jülich, D-54245 Jülich, Germany.

Viacheslav Bolnykh (V)

Laboratory of Computational Chemistry and Biochemistry, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.

Emiliano Ippoliti (E)

Institute for Advanced Simulation (IAS-5) and Institute of Neuroscience and Medicine (INM-9), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
JARA-HPC, Forschungszentrum Jülich, D-54245 Jülich, Germany.

Simone Meloni (S)

Dipartimento di Scienze Chimiche e Farmaceutiche, Università degli Studi di Ferrara, Via Luigi Borsari 46, I-44121 Ferrara, Italy.

Jógvan Magnus Haugaard Olsen (JMH)

Hylleraas Centre for Quantum Molecular Sciences, Department of Chemistry, UiT The Arctic University of Norway, N-9037 Tromsø, Norway.

Thomas Beck (T)

Department of Chemistry, University of Cincinnati, Cincinnati, Ohio 45221, United States.

Ursula Rothlisberger (U)

Laboratory of Computational Chemistry and Biochemistry, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.

Christoph Fahlke (C)

Institute of Biological Information Processing (IBI-1), Molekular- und Zellphysiologie, Forschungszentrum Jülich, D-54245 Jülich, Germany.

Paolo Carloni (P)

Institute for Advanced Simulation (IAS-5) and Institute of Neuroscience and Medicine (INM-9), Computational Biomedicine, Forschungszentrum Jülich, 52425 Jülich, Germany.
JARA-HPC, Forschungszentrum Jülich, D-54245 Jülich, Germany.
Department of Physics, RWTH Aachen University, 52056 Aachen, Germany.
Institute of Neuroscience and Medicine (INM-11), Molecular Neuroscience and Neuroimaging, Forschungszentrum Julich, 52425 Julich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH